Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria by Melo-Gonzalez, Felipe et al.
 
 
Antigen-presenting ILC3 regulate T cell-dependent
IgA responses to colonic mucosal bacteria
Melo-Gonzalez, Felipe; Kammoun, Hana; Evren, Elza; Dutton, Emma E; Papadopoulou,
Markella; Bradford, Barry M; Tanes, Ceylan; Fardus-Reid, Fahmina; Swann, Jonathan R;
Bittinger, Kyle; Mabbott, Neil A; Vallance, Bruce A; Willinger, Tim; Withers, David R;
Hepworth, Matthew R
DOI:
10.1084/jem.20180871
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Melo-Gonzalez, F, Kammoun, H, Evren, E, Dutton, EE, Papadopoulou, M, Bradford, BM, Tanes, C, Fardus-
Reid, F, Swann, JR, Bittinger, K, Mabbott, NA, Vallance, BA, Willinger, T, Withers, DR & Hepworth, MR 2019,
'Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria' The Journal of
Experimental Medicine, vol. 216, no. 3, jem.20180871. https://doi.org/10.1084/jem.20180871
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 05/03/2019
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 29. Apr. 2019
BRIEF DEFINITIVE REPORT
Antigen-presenting ILC3 regulate T cell–dependent
IgA responses to colonic mucosal bacteria
Felipe Melo-Gonzalez1,2, Hana Kammoun3, Elza Evren3, Emma E. Dutton4, Markella Papadopoulou1,2, Barry M. Bradford5, Ceylan Tanes6,
Fahmina Fardus-Reid7, Jonathan R. Swann7, Kyle Bittinger6, Neil A. Mabbott5, Bruce A. Vallance8, Tim Willinger3, David R. Withers4, and
Matthew R. Hepworth1,2
Intestinal immune homeostasis is dependent upon tightly regulated and dynamic host interactions with the commensal
microbiota. Immunoglobulin A (IgA) produced by mucosal B cells dictates the composition of commensal bacteria residing
within the intestine. While emerging evidence suggests the majority of IgA is produced innately and may be polyreactive,
mucosal-dwelling species can also elicit IgA via T cell–dependent mechanisms. However, the mechanisms that modulate the
magnitude and quality of T cell–dependent IgA responses remain incompletely understood. Here we demonstrate that group 3
innate lymphoid cells (ILC3) regulate steady state interactions between T follicular helper cells (TfH) and B cells to limit
mucosal IgA responses. ILC3 used conserved migratory cues to establish residence within the interfollicular regions of the
intestinal draining lymph nodes, where they act to limit TfH responses and B cell class switching through antigen presentation.
The absence of ILC3-intrinsic antigen presentation resulted in increased and selective IgA coating of bacteria residing within
the colonic mucosa. Together these ﬁndings implicate lymph node resident, antigen-presenting ILC3 as a critical regulatory
checkpoint in the generation of T cell–dependent colonic IgA and suggest ILC3 act to maintain tissue homeostasis and
mutualism with the mucosal-dwelling commensal microbiota.
Introduction
Homeostatic colonization of the gastrointestinal tract by the
commensal microbiota is increasingly appreciated to modulate a
wide range of basic biological processes including behavior,
pathogen colonization, nutrient uptake, and immune develop-
ment (Hooper et al., 2012; Belkaid and Hand, 2014; Honda and
Littman, 2016). In contrast, dysregulated responses toward
commensal bacteria, or shifts in the composition of the intestinal
microbiota that favor the outgrowth of opportunistic bacterial
pathobionts, have been associated with disease pathology in a
wide range of conditions, including inﬂammatory bowel disease.
As such, host interactions with the intestinal microbiota are
tightly regulated to maintain tissue health and homeostasis. This
is in part achieved via physical segregation of the vast majority
of commensal microbiota from the underlying tissue by the
production of highly organized mucus layers, which are rich in
antimicrobial peptides, and through the maintenance of epi-
thelial barrier integrity to prevent bacterial translocation
(Hooper et al., 2012; Belkaid and Hand, 2014; Honda and
Littman, 2016). Nonetheless, physical segregation of commen-
sal microbes is not absolute, and some commensal species have
adapted to thrive within the mucosal layer or epithelial niche,
yet are tolerated under homeostatic circumstances and do not
elicit inﬂammation in the healthy intestine (Honda and Littman,
2016). However, the underlying mechanisms for this phenom-
enon remain incompletely understood.
Tolerance toward the commensal microbiota is further
maintained by the intestinal immune system. A broad range of
immune-mediated mechanisms have coevolved to cooperatively
suppress inﬂammatory responses against otherwise beneﬁcial
commensal microbes and to prevent inﬂammation in the gas-
trointestinal tract. Among these the production of mucosal an-
tibodies, particularly IgA, by tissue-resident B cells is key to
controlling the composition of the intestinal microbiota
(Macpherson et al., 2015; Kubinak and Round, 2016). IgA acts by
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excluding bacterial access to the underlying tissue by neutral-
izing bacterial toxins and through agglutination or enchained
growth of targeted bacterial species—which together act to reduce
colonization and increase shedding in the feces (Macpherson et al.,
2015; Kubinak and Round, 2016; Moor et al., 2017). Conversely,
IgA can also help to promote mutualism by selecting for com-
munities of bacteria with beneﬁcial properties (Fagarasan et al.,
2010).
IgA can be generated via distinct mechanisms, either in a
T cell–independent manner or via coordinated interactions with
T follicular helper cells (TfH) in lymphoid tissues that select for
high-afﬁnity B cell clones, and promotes class switching within
germinal centers (GCs). However, the mechanisms that control
the magnitude and quality of IgA responses to commensal bac-
terial species are incompletely understood. Recent studies have
indicated the majority of IgA produced at steady state is pro-
duced in a T cell–independent manner and secreted within the
small intestine, rather than the colon where the microbial load is
highest (Bunker et al., 2015). Moreover, the vast majority of the
small intestinal IgA repertoire appears to be polyreactive and is
present even in the absence of the microbiota (Bunker et al.,
2017). In contrast, under homeostatic conditions only a small
subset of commensal bacterial species elicit T cell–dependent
IgA responses and exhibit a relatively enhanced level of IgA
coating (Palm et al., 2014; Bunker et al., 2015). The reasons why
some bacterial species preferentially trigger a T cell–dependent,
high-afﬁnity IgA response under homeostatic conditions is un-
clear; however, emerging evidence suggests these bacterial
species may be preferentially localized within relatively im-
munostimulatory niches such as the mucus layer or in close
contact with the intestinal epithelium (Palm et al., 2014; Bunker
et al., 2015). These bacterial populations have been suggested to
have an increased propensity to drive colitis when intestinal
homeostasis is perturbed, and thus their residence within the
gut must be tightly controlled by the immune system. In con-
trast, high-afﬁnity IgA has been suggested to support mutualism
by supporting, reﬁning, and maintaining commensal bacterial
communities, and colonization of mucosal-dwelling species has
also been suggested to provide mutualistic beneﬁts for the host
at homeostasis (Fagarasan et al., 2010; Sutherland et al., 2016;
Campbell et al., 2018; Donaldson et al., 2018). Despite these ad-
vances, the mechanisms that act to regulate the quality and
magnitude of T-dependent antibody responses toward com-
mensal bacteria in the intestine remain poorly understood.
Innate lymphoid cells (ILCs) are a family of transcriptionally
poised, tissue-resident effector cells with critical roles in intes-
tinal immunity and inﬂammation (Klose and Artis, 2016). In
particular, RORγt+ group 3 ILC (ILC3) are key regulators of in-
testinal homeostasis and promote host–microbiota mutualism
through constitutive production of cytokines, such as IL-22,
which acts on intestinal epithelial cells to reinforce barrier in-
tegrity and to induce epithelial cell fucosylation and antimi-
crobial peptide secretion (Sonnenberg and Artis, 2012; Klose
and Artis, 2016). In addition to their role as effector cells,
ILC3 are increasingly appreciated to have broader immunoreg-
ulatory functions via interactions with the adaptive immune
system (Hepworth and Sonnenberg, 2014; Melo-Gonzalez and
Hepworth, 2017). In particular, ILC3 help to maintain tissue-
resident regulatory T cell (T reg) populations through GM-
CSF–mediated effects on tolerogenic myeloid populations
(Mortha et al., 2014). Moreover, CCR6-expressing lymphoid
tissue inducer (LTi)–like ILC3 highly express MHCII and exhibit
antigen-presenting function and have been demonstrated to
directly suppress inﬂammatory effector CD4+ T cell responses
toward commensal antigens in the intestinal-draining mesen-
teric lymph node (mLN; Hepworth et al., 2013, 2015). LTi-like
ILC3 also selectively localize within the mLN at the interface
between T cells and B cells (Mackley et al., 2015), provoking the
hypothesis that ILC3 have roles in regulating the generation of
antibody responses within the gastrointestinal tract and asso-
ciated lymphoid tissue. In this regard, ILC3 have previously been
demonstrated to modulate T cell–independent B cell responses
and antibody production via the production of lymphotoxin and
B cell survival factors such as BAFF and APRIL (Kruglov et al.,
2013; Magri et al., 2014; Reboldi et al., 2016). However, whether
ILC3 populations also orchestrate T cell–dependent IgA re-
sponses toward the commensal microbiota is not known.
In this study, we demonstrate that ILC3 colocalization within
the interfollicular regions of the mLN facilitates MHCII-
dependent regulation of TfH responses and limits GC re-
actions. Presentation of antigen by ILC3 to TfH was required to
suppress the subsequent generation of colonic IgA+ B cell re-
sponses against both commensal and pathogenic bacterial spe-
cies residing within the mucosa of the large intestine. Together,
these studies suggest ILC3 act as an important checkpoint in the
generation of T cell–dependent, antigen-speciﬁc IgA responses
to commensal microbes in the colon under homeostatic con-
ditions. ILC3 regulation of colonic IgA may play a critical role in
maintaining tissue homeostasis by controlling the mutualism
with commensal species that establish residence in the host
mucosal niche.
Results and discussion
ILC3 establish residence within the interfollicular region of the
mLN and interact with TfH cells through sensing of
migratory cues
ILC3 have emerging roles in the regulation of adaptive immunity
and have been shown to localize at the boundary between the
T cell zone and B cell follicles within lymph nodes (Mackley
et al., 2015). However, the functional importance of this locali-
zation and the molecular machinery required for positioning of
ILC3 within this lymph node niche remain incompletely deﬁned.
The interfollicular regions of lymphoid tissues are critical sites
for initial interactions between specialized TfH cells and cognate
B cells that ultimately result in GC reactions and the production
of high-afﬁnity antibody (Kerfoot et al., 2011; Vinuesa and
Cyster, 2011). Analysis of ILC3 localization using serial sections
indicated that CD3−RORγt+CD127+ ILC3 colocalized and formed
frequent contacts with CD3+Bcl6+ T cells in the interfollicular
region, at the border of B cell follicles also containing CD3−Bcl6+
GC B cells (Fig. 1, A–C; and Fig. S1 A). Interactions between TfH
and B cells in this lymph node niche are elegantly orchestrated
by transcription factors, local migratory gradients, and tightly
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regulated expression of a range of chemokine receptors
(Vinuesa and Cyster, 2011). Thus, we hypothesized that ILC3
localization within the interfollicular niche may be dictated
through similar pathways. To test this hypothesis, CCR6+RORγt+
LTi-like ILC3 were sort-puriﬁed from the mLN of RORγteGFP
reporter mice alongside RORγt− ILCs, TfH, and B cells and as-
sessed for migratory receptors that are known to facilitate T–
B cell interactions (Fig. 1, D and E). Lymph node ILC3 were found
to express G protein–coupled receptor 183 (Gpr183, also known as
EBI2), as recently described (Chu et al., 2018; Emga˚rd et al.,
2018), as well as Cxcr5—at levels similar to B cells and TfH, re-
spectively (Fig. 1 E and Fig. S1 B). In addition, ILC3 expressed
moderate levels of the transcription factor Bcl6 at the mRNA
level (Fig. 1 E), although we were unable to consistently detect
Bcl6 protein in ILC3 (data not shown). Together, these data in-
dicate that LTi-like ILC3 may use conserved molecular ma-
chinery to establish residence at interfollicular sites within the
lymph node, and that they may be ideally located to modulate
TfH and potentially inﬂuence downstream induction of B cell
responses and antibody production.
To determine the relative contribution of ILC3-expressed
migratory receptors, we examined ILC3 localization in the
lymph nodes of mice lacking Gpr183, Cxcr5, or Ccr6—the last a
deﬁning surface marker of LTi-like ILC3 and central regulator of
follicular B cell dynamics and GC reactions (Reimer et al., 2017).
Gpr183 directs the localization of lymphocytes through sensing of
Figure 1. LTi-like ILC3 localize to inter-
follicular regions of the mLN and interact
with TfH cells. (A and B) Serial sections of mLN
demonstrating (A) positioning of RORγt+CD127+
CD3− ILC3 and (B) colocalization of CD127+CD3−
ILC with CD127−CD3+Bcl6+ TfH cells in wild-type
C57BL/6 mice (n = 6), representative of two in-
dependent experiments. Dotted line indicates
follicular border. Bars, 100 µm. (C) Higher
magniﬁcation image of insert indicated in B. Ar-
rows indicate contacts between ILC3 and TfH
cells in interfollicular region. (D and E) (Live
CD45+/Linneg/CD127+) RORγteGFP+ LTi-like ILC3
(n = 3; blue) and RORγt-negative ILC (n = 3; red)
were sorted from the mLN of RORγteGFP mice
along with (CD3−CD4+) PD-1+ICOS+ TfH (n = 6),
PD-1−ICOS− conventional T cells (n = 6), and
CD19+B220+MHCII+ B cells (n = 6; D) and as-
sessed for expression of Gpr183, Cxcr5, and Bcl6
(E), with data representative of two independent
experiments. (F) Localization of DAPI+RORγt+
CD3− ILC3 in the mLN of Gpr183+/ﬂ control mice
or RorcCre × Gpr183ﬂ/ﬂ mice (n = 5 per group),
representative of two independent experiments.
(G) Localization of CD127+RORγt+CD3− ILC3
in the mLN of Cxcr5ﬂ/ﬂ control mice (n = 6) or
Id2CreERT2 × Cxcr5ﬂ/ﬂ mice (n = 7) treated four
times with tamoxifen and rested for 1 mo, rep-
resentative of two independent experiments.
Bar, 50 µm. All data shown as mean ± SEM.
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tightly regulated gradients of its oxysterol ligand 7α,25-hy-
droxycholesterol, and has recently been demonstrated to be
required for ILC3 migration to intestinal tissue lymphoid
structures—including cryptopatches and isolated lymphoid fol-
licles (Emga˚rd et al., 2018). To investigate the role of Gpr183 in
ILC3 localization further, we visualized ILC3 in the mLN of
RorcCre × Gpr183ﬂ/ﬂ mice, where Gpr183 expression is ablated in
ILC3 (and T cells). In contrast to wild-type controls, in which
RORγt+ ILC3 formed distinct clusters within the interfollicular
regions, Gpr183-deﬁcient ILC3 failed to cluster and were instead
dispersed throughout the lymph node (Fig. 1 F). Gpr183 was not
required for entry into the lymph node per se as ILC3 frequencies
within the mLN of mice were unaffected by deletion of ILC3-
intrinsic Gpr183 (Fig. S1, C and D). Thus, in line with another
recent study, our data suggest Gpr183 is required for ILC3 local-
ization to the interfollicular border of the mLN (Chu et al., 2018).
CXCR5 is a marker of TfH and orchestrates colocalization of
TfH with follicular B cells. In addition, CXCR5 has been de-
scribed as a marker of bona ﬁde fetal LTi cells and is important
for the establishment of normal lymph node architecture (Finke
et al., 2002; Ohl et al., 2003). To test the role of this chemokine
receptor in ILC3 positioning within the adult lymph node, we
generated Id2CreERT2 ROSARFP × Cxcr5ﬂox/ﬂox mice (hereafter re-
ferred to as Cxcr5ΔILC), which allow for the inducible deletion of
CXCR5 in ID2-expressing ILC and thus circumvent any potential
developmental effects on lymphoid tissue formation. RFP+ ILC3
from tamoxifen-treated Cxcr5ΔILC mice were conﬁrmed to have
effective gene deletion in comparison to RFP+ ILC3 from CXCR5+/+
controls (Fig. S1 E). However, immunoﬂuorescence imaging of
ILC3 revealed that CXCR5 was not absolutely required to
maintain ILC3 residency in the interfollicular region once es-
tablished (Fig. 1 G). Similarly, CCR6 was also dispensable for
ILC3 localization within the interfollicular niche of the mLN
(Fig. S1 F). Together these ﬁndings indicate lymph node–
resident LTi-like ILC3 use sensing of cholesterol ligand cues via
Gpr183 to establish residence within the interfollicular border
where they interact with TfH.
Interfollicular LTi-like ILC3 limit homeostatic TfH and B cell
responses and colonic IgA
The observation that ILC3 are found in contact with TfH pop-
ulations provoked the possibility that ILC3 may modulate
T-dependent B cell responses in the intestinal-draining lymph
node. We have previously demonstrated that one major mech-
anism through which LTi-like ILC3 exert their effects within the
mLN is through the presentation of antigen to CD4+ T cells via
MHCII, and we conﬁrmed MHCII expression on interfollicular-
resident ILC3 by immunoﬂuorescence and by ﬂow cytometry of
CCR6+ LTi-like ILC3 in intestinal tissue and mLN (Fig. S1, G–M;
Hepworth et al., 2013, 2015). Given the close cellular interactions
between ILC3 and TfH within the interfollicular regions, we
hypothesized that steady state TfH responses may be controlled
by ILC3-dependent antigen presentation. To test this hypothesis,
we quantiﬁed TfH in mice that lack ILC3-intrinsic MHCII ex-
pression (MHCIIΔILC3) or in H2-Ab1ﬂ/ﬂ littermate controls in
which antigen-presenting function is intact (Hepworth et al.,
2013, 2015). Notably, 10–12-wk-old mice lacking ILC3-intrinsic
MHCII expression exhibited elevated frequencies of (CD3+CD4+)
CXCR5+PD-1+ TfH at steady state relative to littermate control
mice (Fig. S2, A and B). This increase was speciﬁc to Bcl6+FoxP3−
TfH cells since no difference was observed the numbers of
regulatory FoxP3+Bcl6+ follicular T cells (TfR; Fig. S2, C–E).
These data indicate ILC3 may directly limit TfH responses at
steady state through antigen presentation, independently of
changes in the regulatory TfR cell population. The mLN consists
of a series of discrete individual nodes, which have recently been
demonstrated to differentially drain speciﬁc regions of the gas-
trointestinal tract, and proﬁling of ILC subsets within these in-
dividual nodes suggested MHCII+ ILC3 may be relatively
enriched speciﬁcally in the colon-draining lymph node of the
mLN (Fig. S1, H–J; Houston et al., 2016). Strikingly, we observed
a selective lymphadenopathy in MHCIIΔILC3 mice in the ﬁrst
node of the mLN chain, proximal to the cecum, which has been
demonstrated to be the major colon-draining node of the mLN
(Houston et al., 2016; Fig. 2, A and B). In comparison, the small
intestinal draining nodes remained largely unchanged in size
and cellularity in the absence of ILC3-intrinsic antigen presen-
tation (Fig. 2, A and B). Comparison of TfH frequencies and cell
numbers in the colon-draining or small intestine–draining nodes
of the mLN revealed increased TfH responses that were pre-
dominantly restricted to the colon-draining node of the mLN of
MHCIIΔILC3 mice (Fig. 2, C and D). Collectively, these data sug-
gest that MHCII+ ILC3 may largely act to restrict TfH responses
initiated by antigen derived from the colon rather than the small
intestine.
In line with enhanced TfH activity, GC B cell responses were
increased in the mLN of MHCIIΔILC3 mice as compared with
controls (Fig. 2, E–G). Moreover, mLN-resident B cells from
MHCIIΔILC3 mice had increased Aicda expression—indicative
of somatic hypermutation and class switch recombination
(Fig. 2 H). GC B cells inMHCIIΔILC3 mice demonstrated increased
class switching toward both IgG1 (Fig. S2 F) and IgA (Fig. 2 I).
Strikingly, we also observed a signiﬁcant increase in the fre-
quencies and numbers of IgA+ plasma cells in the colons of
MHCIIΔILC3 mice (Fig. 2, J and K), which was associated with
increased titers of fecal IgA (Fig. 2 L). Moreover, large B cell–
containing lymphoid follicles were observed in the colon of
MHCIIΔILC3 mice, but not in littermate controls (Fig. 2 M)—some
of which also exhibited evidence of active GCs (Fig. S2, G and H).
Notably, the lack of ILC3-intrinsicMHCII had no effect on TfH or
B cell responses in the Peyer’s patches or the small intestinal
lamina propria—the major intestinal site for the induction of
T-independent IgA (Fig. S2, I–N). This further indicates that
MHCII+ ILC3 selectively limit TfH-driven B cell responses and
IgA production in the colon. Nonetheless, as ILC3 have also been
demonstrated to modulate B cell responses and IgA production
directly in a T-independent manner, we further determined
whether loss of ILC3-intrinsic MHCII disrupted broader ILC3
functionality. However, ILC3 from MHCIIΔILC3 mice and litter-
mate controls equally expressed surface lymphotoxin, Tnfsf13
(APRIL) and Dll1 (Fig. S2, O and P)—suggesting intrinsic antigen
presentation rather than changes in the provision of B cell
survival signals accounts for altered B cell responses in
MHCIIΔILC3 mice. Additionally, we have previously demonstrated
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that MHCII-deﬁcient ILC3 are not defective in their ability to
produce IL-22 (Hepworth et al., 2013), and absence of ILC3-
intrinsic MHCII was not associated with dysregulated intestinal
barrier function (Fig. S2 Q). Our data therefore indicate mLN-
resident ILC3 limit TfH responses and mucosal antibody pro-
duction in the colon in the presence of an intact intestinal barrier.
IgA generated in the absence of ILC3 antigen presentation
targets colonic mucosa-resident bacteria
Increasing evidence suggests that, in contrast to innate poly-
reactive IgA responses, T-dependent IgA responses are driven
by bacterial species that reside within the mucosal layer or
attached to the epithelium itself (Palm et al., 2014; Bunker et al.,
2015). To further investigate the relevance of increased IgA re-
sponses in the absence of ILC3-intrinsic antigen presentation,
we isolated bacteria from the colonic mucosa or feces of mice
with a mutated IgH locus (IgHμγ1; subsequently termed IgMi
mice), which lack the ability to class switch and secrete antibody
(Waisman et al., 2007). Thus, commensal bacteria isolated from
these mice lacked endogenous IgA coating (“unlabeled”; Fig. 3 A
and Fig. S3 A). Incubation of fecal bacteria from IgMi mice with
fecal-derived supernatants, containing free IgA, taken from
MHCIIΔILC3 mice and littermate controls resulted in surprisingly
low levels of IgA coating (Fig. S3, A and B). In contrast, bacteria
Figure 2. Antigen-presenting LTi-like ILC3 limit the colon-associated TfH–B cell axis and IgA production. (A and B) Images of mLN chains with colon
(col) and small intestinal (si) draining lymph nodes indicated (A) and cell counts of colonic or small intestinal draining nodes isolated from RorcCre x H2-Ab1ﬂ/ﬂ
mice (MHCIIΔILC3; n = 14) and H2-Ab1ﬂ/ﬂ littermate controls (n = 5; B), representative of at least three independent experiments. (C and D) Representative ﬂow
cytometry plots (C) and cell numbers of (live CD45+/CD3+CD4+/CD25−GITR−)CXCR5+PD1+ TfH in colon and small intestinal draining lymph nodes isolated from
MHCIIΔILC3 mice (n = 14) and H2-Ab1ﬂ/ﬂ littermate controls (n = 5; D), representative of at least three independent experiments. (E–G) Representative ﬂow
cytometry plots (E), cell frequencies (F), and cell numbers (G) of mLN (live CD45/CD3−MHCII+/B220+CD19+)GL7+Fas+ GC B cells isolated from MHCIIΔILC3 mice
(n = 7) and H2-Ab1ﬂ/ﬂ littermate controls (n = 5), representative of eleven independent experiments. (H) Relative expression of Aicda by sort-puriﬁed B cells (n = 6),
pooled from two independent experiments. (I) Representative surface staining of IgA from class-switched B cells from E–G. (J and K) Representative ﬂow cytometry
plots (J) and cell numbers of (live CD45+/CD3−MHCII+)IgA+CD138+ plasma cells in the colonic lamina propria (cLPL) isolated from MHCIIΔILC3 mice (n = 11) and
H2-Ab1ﬂ/ﬂ littermate controls (n = 10; K); data are pooled from two experiments and representative of four independent experiments in total. (L) Concentration of
free IgA measured by ELISA in feces isolated from MHCIIΔILC3 mice (n = 11) and H2-Ab1ﬂ/ﬂ littermate controls (n = 7) and representative of three independent
experiments. (M) Histological analysis of B220+ cells in colonic swiss rolls isolated from MHCIIΔILC3 mice and H2-Ab1ﬂ/ﬂ littermate controls (n = 4–5 per group), with
three independent experiments. Bars, 1,000 µm. All data shown as mean ± SEM and analyzed by Mann–Whitney U test; **P ≤ 0.01; ***P ≤ 0.001.
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isolated from the colonic mucosa of IgMi mice exhibited a sig-
niﬁcant degree of IgA labeling following incubation (Fig. 3 A).
Notably, IgA-containing supernatants from MHCIIΔILC3 mice
resulted in a much higher level of IgA coating of colonic
mucosa–associated bacteria in comparison to those incubated
with IgA-containing supernatants from littermate controls
(Fig. 3, A and B). To determine whether altered IgA responses in
the absence of ILC3-intrinsic antigen presentation altered the
composition of the commensal microbiota, 16S ribosomal RNA
(rRNA) sequencing was performed on total bacteria isolated
from either the feces or colonic mucosa of MHCIIΔILC3 mice and
cohoused littermate controls (Fig. 3 C). While no signiﬁcant
differences were detected among major operational taxonomic
units (OTUs) in fecal preparations, in linewith previous ﬁndings
(Hepworth et al., 2013), total bacteria populations in the colonic
mucosa of MHCIIΔILC3 mice contained relatively less Heli-
cobacteraceae in comparison to H2-Ab1ﬂ/ﬂ controls, whereas
Clostridiales were relatively enriched (Fig. 3 C). The decreased
relative abundance of Helicobacter spp. was conﬁrmed by
quantitative PCR (qPCR) and found to be in part due to a reduced
abundance of Helicobacter typhlonius (Fig. 3, D and E). Together
these ﬁndings demonstrate that changes in microbial composi-
tion resulting from the absence of ILC3-intrinsic antigen pre-
sentation occur largely in colonic mucosa, as opposed to among
luminal-dwelling species.
To determine whether alterations in colonic mucosal bacteria
were driven by elevated IgA production in MHCIIΔILC3 mice, we
performed 16S rRNA sequencing of IgA-bound bacteria (IgA-seq;
Palm et al., 2014; Bunker et al., 2015). Pairwise UniFrac analysis
of both colon mucosa and fecal bacterial samples fromMHCIIΔILC3
mice and littermate controls revealed signiﬁcant alterations in
microbial composition, which were associated with altered IgA
labeling (Fig. S3 C). Disruption of ILC3-intrinsic antigen pre-
sentation resulted in a signiﬁcant enrichment in the IgA-labeling
ratio of the Helicobacter genus as well as the Deferribacteres
genus Mucispirillum (Fig. 3 F). Conversely, a degree of decreased
IgA labelingwas also observed in the colonmucosa ofMHCIIΔILC3
mice and resulted in small but signiﬁcant increases in the total
relative abundance of Clostridiales and Lachnospiraceae within
the colonic mucosal niche (Fig. S3 F). Differences in colonic
mucosa–associated bacteria were not due to a breakdown in
homeostatic containment since normal segregation of bacteria
was maintained inMHCIIΔILC3 mice, as conﬁrmed by ﬂuorescent
in situ hybridization (FISH) staining with a universal bacterial
16S probe (Fig. S3 D). Notably, the increased abundance of Hel-
icobacter and Mucispirillum was seen in the IgA+ fraction of
MHCIIΔILC3 mice not only in the colonic mucosa, but also in the
feces (Fig. 3 G)—despite normally being poorly represented in
fecal communities (Fig. S3 E)—suggesting elevated IgA labeling
may favor shedding in the feces. In line with this, enrichment of
Helicobacter was conﬁrmed within the IgA+ fraction of fecal
bacterial samples by qPCR and was attributed in part to in-
creased H. typhlonius, but not Helicobacter hepaticus—a related
species often used as a model of intestinal inﬂammation
(Fig. 3 H). To determine whether changes in the mucosal-
dwelling microbiota in mice lacking ILC3-intrinsic antigen pre-
sentation could have broader physiological effects, we performed
1H nuclear magnetic resonance (NMR) spectroscopy–based
metabolic proﬁling on fecal samples to assess the relative met-
abolic proﬁles. Several metabolites were observed to differ be-
tween groups, including those related to gut microbial activity
(Fig. 3 I). Mice lacking ILC3-intrinsic MHCII excreted lower
amounts of the short chain fatty acids acetate and propionate.
Moreover, several amino acids known to be metabolized by the
intestinal microbiota were present in higher amounts in the
feces of MHCIIΔILC3 mice compared with their littermate coun-
terparts, potentially reﬂecting a reduction in their microbial
degradation. These functional modulations in the microbiota
mirrored those recently reported in mice lacking mice lacking
extrathymically generated regulatory T cells—which also cor-
related with the reduced abundance of both Helicobacter and
Mucispirillum in the intestinal mucosa (Campbell et al., 2018).
Together these ﬁndings suggest antigen-presenting ILC3 act to
suppress the induction of IgA responses toward colonic
mucosal–dwelling bacteria in order to maintain mutualism.
ILC3 antigen presentation regulates IgA responses to enteric
pathogen infection
While our data, along with recently published studies, support
the hypothesis that ILC3-intrinsic antigen presentation acts to
suppress IgA labeling of mutualistic colonic mucosal–dwelling
commensal bacteria species at steady state, it is notable that the
same species have been attributed pathobiont potential in the
context of a maladapted immune system (Honda and Littman,
2016). Moreover, the ability to establish residence within the
mucus and/or epithelial niche is a characteristic also shared by
pathogenic bacteria; thus, we investigated the hypothesis that
antigen-presenting ILC3 could similarly play a role in limiting
antibody responses to mucosal dwelling pathogens. To test this,
MHCIIΔILC3 mice and littermate controls were infected with
Citrobacter rodentium–enhanced GFP (eGFP), which allowed for
detection of GFP+ bacteria in the feces and colonic mucosa of
infected mice (Fig. 4 A). To limit the impact of commensal
bacteria-driven phenotypes in MHCIIΔILC3 mice, we used 6–7-
wk-old mice for infection experiments, an age at which we have
previously demonstrated these mice do not yet demonstrate a
notable phenotype (Hepworth et al., 2013), and which was be-
fore the age at which increases in TfH and B cells were observed
(10–12 wk old; Fig. 2). Loss of ILC3-intrinsic MHCII expression
had no signiﬁcant effect on C. rodentium infection–induced body
weight loss, bacterial burdens, or C. rodentium antigen–speciﬁc
effector T helper type 17 cell responses when compared with
control mice (Fig. 4, B and C; and Fig. S3 G). In line with a lack of
basal commensal bacteria-driven phenotype at this time point,
no difference in homeostatic mLN TfH numbers was observed
between uninfected naive MHCIIΔILC3 mice and control litter-
mates at this age (Fig. 4 D). In contrast, infection with C.
rodentium–eGFP elicited a robust TfH response in MHCIIΔILC3
mice, which was largely lacking in control littermates (Fig. 4 D).
While disruption of ILC3 antigen presentation resulted in in-
creased numbers of IgG1 class-switched B cells, little endogenous
IgG1 labeling of mucosal-associated C. rodentium–eGFP bacterium
was seen irrespective of genotype (Fig. S3, H and I), supporting
reports that IgG1 is largely generated systemically and excluded
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from the intestinal lumen in the absence of signiﬁcant barrier
disruption (Kamada et al., 2015). Critically, however, infection
of MHCIIΔILC3 mice resulted in an increased frequency of C.
rodentium–eGFP bacteria exhibiting labeling by IgA in the colonic
mucosa and a higher intensity of IgA labeling in comparison to
littermate controls (Fig. 4, E and F).
LTi-like ILC3 limit TfH-mediated B cell class switching in an
MHCII and IL-4–dependent manner
To determine whether antigen presentation by LTi-like ILC3
directly modulates TfH function and their ability to stimulate
B cell class switching, we cocultured TfH and B cells isolated
from mice immunized with 4-hydroxy-3-nitrophenylacetyl
(NP)–OVA in CFA, as previously described (Sage and Sharpe,
2015; Sage et al., 2016). Coculture with TfH induced a popula-
tion of IgG1+GL7+ class-switched B cells, which could be sup-
pressed by the addition of TfR, as previously described (Sage
et al., 2016; Fig. 5 A). Similarly, addition of ILC3 to TfH–B cell
cocultures resulted in reduced frequencies of class-switched
B cells and was dependent on antigen presentation via MHCII
(Fig. 5, A and B). While this assay did not allow for modeling of
mucosal IgA class switching, these data nonetheless successfully
provided proof of concept that ILC3 directly modulate TfH-
driven class switching in vitro via antigen presentation.
To further investigate how TfH function is modulated in the
absence of ILC3 regulation in vivo, we sort-puriﬁed TfH from
Figure 3. Lack of ILC3 antigen-presentation results in dysregulated IgA coating of mucosal-dwelling bacteria in the colon. Bacteria isolated from the
colonic mucosa of IgMi mice, which lack endogenous secreted IgA, were cocultured with fecal supernatants containing free IgA. (A and B) Representative
histogram of IgA labeling of bacteria without incubation (unlabeled; gray ﬁll) or cultured with fecal supernatant isolated from MHCIIΔILC3 mice (n = 3, blue line)
and H2-Ab1ﬂ/ﬂ littermate controls (n = 3, black line; A) and frequencies of IgA-labeled bacteria (B), representative of two independent experiments. (C)
Quantiﬁcation of total bacterial families with a relative abundance >2% in the colonic mucosa or feces. (D and E) Relative abundance of Helicobacter spp. (D) or
H. typhlonius (E) in total colonic mucosal bacteria preparations from C. (F and G) IgA-seq and log10 (IgA+/IgA−) enrichment score for major taxa with an a-
bundance of at least 1% across all samples in the colonic mucosa (F) and feces (G). Statistical analysis was performed as detailed in the Materials and methods
section and additionally conﬁrmed via Student’s t test. (H) Relative abundance of total Helicobacter spp., H. hepaticus, and H. typhlonius in IgA+ fecal bacterial
samples of MHCIIΔILC3 and H2-Ab1ﬂ/ﬂ mice. (C–H) Analysis of MHCIIΔILC3 (n = 10) and H2-Ab1ﬂ/ﬂ (n = 7) mice, with data pooled from two independent ex-
periments. (I) Relative abundance of metabolites in the feces of MHCIIΔILC3 (n = 14) and H2-Ab1ﬂ/ﬂ (n = 9) mice, representative of pooled data from three
independent experiments. Metabolites selected as signiﬁcant via multivariate analysis and individual Student’s t test comparisons performed. All data shown as
mean ± SEM; all statistical analyses performed by Student’s t test; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.
Figure 4. MHCII+ ILC3 limit IgA responses during C. rodentium infection. (A) Example ﬂow cytometry of colonic mucosal–associated bacteria from naive
mice or mice infected with C. rodentium–GFP. (B–D) Weight curves (B), antigen (Ag)-speciﬁc IL-17A production (C), and mLN TfH cell numbers (D) of C.
rodentium–GFP-infected MHCIIΔILC3 (n = 11) and H2-Ab1ﬂ/ﬂ (n = 5) mice, representative of three independent experiments. (E and F) Example ﬂow cytometry
plots (E) and quantiﬁcation of IgA labeling of C. rodentium–GFP isolated from the colonic mucosa of MHCIIΔILC3 (n = 6) and H2-Ab1ﬂ/ﬂ (n = 3) mice (F). Rep-
resentative of two independent experiments. All data shown as mean ± SEM; statistical analyses by Student’s t test; ***P ≤ 0.001.
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MHCIIΔILC3 mice and littermate controls. We were unable to ﬁnd
any signiﬁcant differences in TfH provision of CD40L (Fig. 5 C)
or expression of Tgfb, Ifng, or Il17a in the absence of ILC3-
intrinsic MHCII (Fig. 5 D). Recent evidence suggests that while
initial TfH interactions with B cells are driven by production of
IL-21 to select high-afﬁnity B cell clones, progression of GC re-
actions and maturation of plasma cells requires a switch in TfH
cytokine production toward a predominantly IL-4–producing
phenotype (Weinstein et al., 2016). To investigate whether
ILC3 antigen presentation acts as a checkpoint in TfH progres-
sion and cytokine production, we ﬁrst analyzed IL-21 and IL-4
mRNA levels in sort-puriﬁed TfH from the mLN by qPCR. While
TfH isolated from MHCIIΔILC3 mice expressed comparable levels
of IL-21 mRNA to their littermate controls, IL-4 message was
signiﬁcantly higher in the absence of ILC3-intrinsic antigen
presentation (Fig. 5, E and F). Similarly, MHCII-deﬁcient ILC3
cocultured with TfH induced more IL-4 protein in culture su-
pernatants when compared with MHCII+ ILC3 (Fig. 5 G). To
determine whether increased IL-4 production by mLN-resident
TfH in the absence of ILC3 antigen presentation contributed
to elevated GC B cell responses and IgA responses against
mucosal-dwelling commensals, MHCIIΔILC3 mice were treated
Figure 5. ILC3 suppress TfH-dependent B cell class switching in an MHCII and IL-4–dependent manner. B cells were sort-puriﬁed and cultured in vitro
alone (n = 12), with TfH (n = 12) or with TfH in combination with either (CD3+CD4+/CXCR5+PD1+)CD25+GITR+ TfR (n = 11), (CD3+CD4+/CXCR5−PD1−)CD25+GITR+
T reg cells (n = 6), wild-type ILC3 (n = 8), or ILC3 from MHCIIΔILC3 mice (n = 6). Statistical comparisons performed by one-way ANOVA; data pooled from three
independent experiments. (A and B) Representative ﬂow cytometry plots (A) and frequencies (B) of (CD3−MHCII+/B220+CD19+)GL7+IgG1+ class-switched B cells.
(C–F) Expression of Cd40l (C), Tgfb, Ifng, and Il17a (D), Il21 (E), and Il4 (F) in sort-puriﬁed B cells, T cells, or TfH assessed by qPCR (n = 3 per group), representative
of two independent experiments. Statistical comparisons performed by Student’s t test. (G) Concentration of IL-4 protein in supernatants from cocultures
containing B cells and TfH cultured with wild-type of MHCII-deﬁcient ILC3, as in A and B. Statistical comparisons performed by Student’s t test. (H and I) Cell
numbers of mLN (CD3−MHCII+/B220+ CD19+)GL7+Fas+ GC B cells (H) and (CD3−MHCII+)B220−IgA+ plasma cells in the cLPL of anti–IL-4 (n = 5) or isotype (n = 5)
control–treated MHCIIΔILC3 and H2-Ab1ﬂ/ﬂ (n = 6) mice (I). (J and K) Relative abundance of Helicobacter spp. (J) and H. typhlonius (K) in total colonic mucosal
bacteria preparations from anti–IL-4 or isotype control–treated MHCIIΔILC3 and H2-Ab1ﬂ/ﬂ mice. (H–K) Statistical comparisons performed by one-way ANOVA;
data representative of two independent experiments. All data shown as mean ± SEM; * P ≤ 0.05, **P ≤ 0.01; ***P ≤ 0.001.
Melo-Gonzalez et al. Journal of Experimental Medicine 9
Antigen-presenting ILC3 regulation of IgA https://doi.org/10.1084/jem.20180871
with anti–IL-4 neutralizing antibody or an isotype control from
6wk of age and comparedwithH2-Ab1ﬂ/ﬂ littermates. Strikingly,
while isotype control–treated mice developed increased GC
B cell responses in the colon-draining mLN and elevated num-
bers of IgA+ plasma cells, mice treated with anti–IL-4 developed
a markedly suppressed GC response in the mLN and had sig-
niﬁcantly reduced numbers of IgA+ plasma cells in the colon
(Fig. 5, H and I). Moreover, mice treated with anti–IL-4 antibody
retained signiﬁcantly higher levels of mucosal-associated Heli-
cobacter in comparison to isotype-treated control mice, including
higher levels of H. typhlonius—although this did not reach sta-
tistical signiﬁcance (Fig. 5, J and K).
Collectively these ﬁndings suggest localization of antigen-
presenting LTi-like ILC3 within the colon-draining lymph
node facilitates interactions with TfH and the subsequent reg-
ulation of mucosal IgA responses toward the commensal mi-
crobiota, particularly species that establish residence in “border
niches” such as the mucosa or epithelium. Our data suggest that
common pathways that orchestrate the localization and inter-
actions of multiple cell types within the interfollicular niche of
the mLN—including TfH, B cells, and ILC3—may have impor-
tant roles in orchestrating IgA responses and mutualism with
the commensal microbiota to maintain intestinal health. Inter-
estingly, polymorphisms in Gpr183, Cxcr5, and Ccr6 have all been
identiﬁed as risk alleles for inﬂammatory bowel disease (Jostins
et al., 2012), suggesting aberrant positioning of immune cells,
including ILC3, could predispose to intestinal disease—although
our ﬁndings indicate only Gpr183 is absolutely required for ILC3
localization within the mLN. Of note, Gpr183-dependent posi-
tioning of MHCII+ ILC3 at the interface between the T cell zone
and B cell follicle overlaps with the recently described distri-
bution of mLN stromal cells expressing Ch25h—the key enzyme
for generation of the Gpr183 ligand 7α,25-hydroxycholesterol—
suggesting chemokine gradients orchestrated by deﬁned stromal
populations determine positioning of ILC3 in both the colon and
the lymph node, in line with recent publications (Chu et al.,
2018; Emga˚rd et al., 2018; Rodda et al., 2018). Intriguingly,
ILC2 have also been shown to localize to this interfollicular niche
and also have the capacity to express both MHCII as well as
costimulatory molecules that may endow the cells with the
ability to modulate TfH responses (Oliphant et al., 2014;
Schwartz et al., 2017; Halim et al., 2018), while ILC2 also
produce soluble factors that can positively regulate B cell re-
sponses (Moro et al., 2010; Jackson-Jones et al., 2016). Further
studies are required to determine whether ILC3 and ILC2
antagonistically modulate TfH and B cell responses in health
and disease.
Our ﬁndings further implicate interactions with ILC3 and
TfH in the intestinal draining lymph node as key regulators of
intestinal B cells and IgA responses toward mucosal bacteria.
However, it should be noted that we also observed formation of
B cell–containing isolated lymphoid follicles in the colon
(Fig. 2 M) and, while we found no evidence for TfH responses
locally in the tissue, we cannot rule out secondary interactions
between ILC3 and adaptive immune cells in the colon itself.
Interactions between the host and the microbiota are dynamic,
and both innate and T cell–dependent IgA have been shown to be
critical in regulating intestinal bacterial mutualism and for se-
lecting and maintaining reﬁned communities of bacteria with
beneﬁcial properties (Fagarasan et al., 2010; Sutherland et al.,
2016). Recent studies have demonstrated that the majority of IgA
is induced within the small intestinal tract in a T cell–
independent manner and is polyreactive (Bunker et al., 2017).
However, in this study, the absence of ILC3-intrinsic MHCII had
no effect on TfH and IgA responses in the small intestine–
draining lymph node, small intestinal lamina propria, and as-
sociated Peyer’s patches. In contrast, we observed a marked
regulation of TfH and GC B cells in the colon-draining mLN,
which further correlated with the numbers of IgA-producing
plasma cells in the colon lamina propria and IgA-labeling of
colonic mucosal–dwelling bacteria. The reasons for this tissue
compartmentalization and speciﬁcity are unclear, but it is no-
table that the distribution and MHCII expression of ILC3 differs
in these tissues (Fig. S1), as does microbial load, while studies to
elucidate how and where ILC3 acquire commensal bacteria-
derived antigen will likely be highly informative in dissecting
this immunological cross-talk further. ILC3 regulated TfH re-
sponses through MHCII-dependent suppression of IL-4, thus
preventing the elevated GC responses and IgA production that
develop in the absence of ILC3 antigen presentation. Further
studies are required to determine the precise nature of ILC3
interactions with TfH and the full consequences of this inter-
action on TfH function—in particular whether antigen-
presenting ILC3 use additional costimulatory or coinhibitory
signals to modulate TfH survival, proliferation, or function.
Increased T cell–dependent IgA coating has previously been
suggested to preferentially target bacteria that reside close to the
host epithelial layer or within the mucus layer, which may be
inherently more immunostimulatory or which could possess an
increased potential to drive intestinal inﬂammation in the con-
text of a maladapted immune system or inﬂammation (Palm
et al., 2014; Bunker et al., 2015). These ﬁndings provoke the
question as to why ILC3 would limit homeostatic IgA responses
to mucosal-resident bacterial species, which may have patho-
biont potential. However, while Helicobacter species have been
demonstrated to act as pathobionts in the context of a malad-
apted immune system, it is of note that Helicobacter primarily
induce regulatory responses in healthy immunocompetent mice
(Kullberg et al., 2002, 2006; Chai et al., 2017; Danne et al., 2017;
Xu et al., 2018). Furthermore, one recent study elegantly dem-
onstrated a mutualistic role for both Helicobacter and Mucispir-
illum colonization of the mucosa early in life (Campbell et al.,
2018). Notably, in this study failure of these bacterial species to
colonize in the absence of regulatory T cells was associated with
a dysregulated metabolome and affected host growth. Strikingly,
comparable changes in intestinal metabolites were also found in
this study, where mucosal-dwelling species were also lost from
this colonic niche as a consequence of elevated IgA responses in
the absence of ILC3 regulation. Together this suggests mucosal-
dwelling bacteria, including Helicobacter, may normally confer
beneﬁts to the host, despite their pathobiont potential, and that
ILC3 act as a checkpoint to control the quality and magnitude
of T-dependent IgA in order to support mutualism with the
mucosal-dwelling microbiota.
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Materials and methods
Mice
Age- and sex-matched C57BL/6 mice were purchased from En-
vigo Laboratories. Id2CreERT2 mice were originally purchased
from The Jackson Laboratory. ROSA-26RFP mice were a gift
from Hans-Joerg Fehling (University Clinics, Ulm, Germany).
CXCR5ﬂox/ﬂox mice were generated as previously described
(Bradford et al., 2017). RorcCre x H2-Ab1ﬂox/ﬂox (MHCIIΔILC3) and
H2-Ab1ﬂox/ﬂox littermate controls were generated as previously
described (Hepworth et al., 2013), and generated through
breeding of MHCIIΔILC3 males with H2-Ab1ﬂox/ﬂox females to
control for vertical transmission. Experimental littermate
progeny were subsequently cohoused with random distribution
of genotypes among cages. RorcCre × Gpr183ﬂox/ﬂox mice were
generated as recently described (Emga˚rd et al., 2018), and
maintained at the Karolinska Institute, Stockholm, Sweden.
RORγteGFPmice were originally a gift fromGerard Eberl (Pasteur
Institute, Paris, France), and IgMi mice were originally a gift
from Ari Waisman (IMB Mainz, Mainz, Germany). All trans-
genic mouse strains were used as cohoused littermates and
maintained under speciﬁc pathogen free conditions at the Uni-
versity of Manchester, Manchester, UK, unless otherwise spec-
iﬁed. All animal experiments were performed under license of
the UK Home Ofﬁce and under approved protocols at the Uni-
versity ofManchester. Experiments performed at the Karolinska
Institute were performed under the approval of the Linko¨ping
Animal Experimentation Ethics Committee.
In vivo IL-4 neutralization
Mice were administered 200 µg/ml anti–IL-4 mAb (clone 11B11;
BioXcell) twice weekly (every 3–4 d) for 4 wk. Control groupwas
treated with 200 µg/ml monoclonal IgG1 isotype control (clone
TNP6A7; BioXcell).
Tissue processing
mLN and spleen were processed by passing them through a 70-
µm nylon ﬁlter, and red blood lysis was performed where nec-
essary. For intestinal lamina propria lymphocyte preparations,
intestinal tissue was isolated, associated fat and Peyer’s patches
removed, and tissues cut open longitudinally. Luminal contents
were removed by shaking in cold PBS. Epithelial cells and intra-
epithelial lymphocytes were removed by shaking tissues in
stripping buffer (1 mM EDTA, 1 mM dithiothreitol, and 5% FCS)
for two rounds of 20 min at 37°C. Lamina propria lymphocytes
were isolated by digesting the remaining tissue in 1 mg/ml
collagenase/dispase (Roche) and 20 µg/ml DNase I (Sigma-
Aldrich) for 45 min at 37°C. Liberated cells were then extracted
by passing the tissue and supernatant over a 70-µm nylon ﬁlter
and centrifugation to isolate lamina propria lymphocytes.
Flow cytometry
Single-cell preparations were stained with antibodies to the
following markers: anti-CD25 (clone PC61.5; eBioscience), anti-
CD3 (clone 145-2C11; eBioscience), anti-CD5 (clone 53–7.3;
eBioscience), anti-NK1.1 (clone PK136; eBioscience), anti-GITR
(DTA-1; BioLegend), anti-CD90.2 (clone 30-H12; BioLegend),
anti-B220 (clone RA3-6B2; eBioscience), anti-CD11b (clone M1/
70; eBioscience), anti-CD11c (clone N418; eBioscience), anti-
MHCII (clone M5/114.15.2; eBioscience), anti-CD45 (clone 30-
F11; BioLegend), anti-CD4 (clone GK1.5; BD), anti-ICOS (clone
15F9; BioLegend), anti-CXCR5 (L138D7; BioLegend), anti-PD-1
(clone RMP1-30; BioLegend), anti-IgG1 (clone RMG1-1; Bio-
Legend), anti-Fas (clone 15A7; eBioscience), anti-GL7 (clone GL7;
BioLegend), anti-CD38 (clone 90; eBioscience), anti-CD19 (clone
1D3; BD), anti-IgA (clone mA-6E1; eBioscience), anti-IgD (clone
11-26c.2a; BioLegend), anti-CD138 (clone 281–2; BioLegend), anti-
CCR6 (clone 29-2L17; eBioscience; or clone 140706; R&D Sys-
tems), anti-CD127 (clone A7R34; eBioscience), anti-CD90.2
(clone 30-H12; BioLegend), anti-KLRG-1 (clone 2F1; eBioscience),
anti-NKp46 (clone 29A1.4; eBioscience), biotin anti-CXCR5
(clone 2G8; BD), and biotin anti-ST2 (clone RMST2-33; eBio-
science). Dead cells were excluded from analysis using the LIVE/
DEAD Fixable Aqua Dead Cell Stain (Life Technologies). Intra-
cellular staining was performed using the FoxP3 Transcription
Factor Buffer set (eBioscience), and cells were stained for anti-
FoxP3 (FJK-16s; eBioscience), anti-RORγt (clone B2D; eBio-
science), and anti-Bcl6 (clone 7D1; BioLegend). For LTα1β2 de-
tection, cells were blocked with donkey anti-mouse IgG Fab
fragments (Jackson ImmunoResearch) and then stained with
recombinant mouse LTβR Fc chimera (R&D Systems). Cells were
stained with biotin-conjugated donkey anti-mouse IgG (Jackson
ImmunoResearch) followed by staining with antibodies and
APC-conjugated streptavidin (eBioscience).
Bacterial ﬂow cytometry
Feces were collected in Fast Prep lysing Matrix A tubes (MP
Biomedicals), resuspended in 1 ml of PBS per 100 mg fecal ma-
terial, and incubated at 4°C for 20 min. Colon mucosal samples
were isolated by removing feces and loose material associated
with the colon tissue and scraping along the length of a colon
with a cell scraper (Greiner Bio One) into fresh cold PBS. Bac-
terial suspensions were resuspended in a ﬁnal volume of 2 ml
PBS and incubated at 4°C for 20 min. Samples were homoge-
nized in a FastPrep-24 Tissue homogenizer (MP Biomedicals) for
30 s. After homogenization, samples were centrifuged at 50 × g
for 15 min at 4°C to remove debris and the bacteria-containing
supernatant transferred through 70 µm ﬁlters into a new tube.
Bacteria were washed in FACS buffer (PBS, 2% FCS, and 5 mM
EDTA) and pelleted at 8,000 × g for 5 min. For ﬂow cytometry,
bacterial pellets were resuspended in 100 µl FACs buffer con-
taining SYTO 9 green ﬂuorescent nucleic stain (10 µM; Life
Technologies), incubated at 4°C for 15 min, and subsequently
stained with 1 µg/ml of an anti-mouse IgA-PE antibody (eBio-
science) for 30 min at 4°C. Samples were thoroughly washed
before acquisition on the ﬂow cytometer (BD Fortessa).
IgA-seq and 16S rRNA sequencing
Fecal or colonic mucosa–associated bacteria were isolated as
detailed above and sorted by magnetic-activated cell sorting
(MACS)to separate IgA+ and IgA− bacterial fractions. Samples
were stained with anti-IgA PE antibody as above, washed, and
incubated in staining buffer with anti-PE MACS beads (Miltenyi
Biotec) as per the manufacturer’s instructions for 30 min at 4°C.
An aliquot of total bacteria was centrifuged before IgA sorting
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for 16S rRNA sequencing analysis. The remaining stained sample
was washed and separated by passing samples over LS-MACS
columns (Miltenyi Biotec). The negative, unbound fraction
(IgA−) was extracted, while the bound IgA+ fraction was further
puriﬁed by a second round of column separation. Samples were
centrifuged and stored at 20°C for further 16S sequencing
analysis. Post-magnetic bead–enriched samples were analyzed
for purity by ﬂow cytometry; positive fractions were ≥85% IgA+,
and negative fractions were typically <5% IgA+.
Bacterial DNA from total and IgA-sorted fecal and colonic
bacteria was isolated using the PowerSoil DNA Isolation Kit
(Cambio Limited) according to the manufacturer’s instructions.
Pre-ampliﬁcation of the V3V4 region of 16S rRNA was per-
formed by PCR in triplicate using Phusion Hot Start II High Fi-
delity Polymerase (Thermo Fisher Scientiﬁc) using previously
published primer pairs containing adaptor sequences for
downsteam use on Illumina platforms. 16S sequencing was
performed by using the Illumina MiSeq platform, and initial
processing and quality assessment of the sequencing data were
performed at the Centre for Genomics, University of Liverpool,
Liverpool, UK, using an in-house pipeline.
16S rRNA sequencing analysis
16S rRNA sequencing was undertaken at the Centre for Genomic
Research, University of Liverpool. Analysis of IgA-seq data were
performed at the Children’s Hospital of Philadelphia Micro-
biome Center, Philadelphia, PA. Sequence data (NCBI BioProject
ID: PRJNA518140) were processed using QIIME version 1.9. Read
pairs were joined to form a complete V3V4 amplicon based on a
minimum overlap of 35 bases and maximum overlap difference
of 15%. The reads were ﬁltered based on a quality threshold of
Q20. OTUs were selected by clustering reads at 97% sequence
similarity using UCLUST v. 1.2.22. Taxonomic assignments were
generated by comparing the representative OTU sequences to
the Greengenes reference database v. 13_8. A phylogenetic tree
was inferred from the OTU data using FastTree2. Similarity
between samples was assessed by weighted and unweighted
UniFrac distance. For statistical analysis, data ﬁles from QIIME
were analyzed in the R environment. Weighted and unweighted
UniFrac distances were used to visualize global differences in
bacterial community compositions using Principal Coordinates
Analysis. Community-level differences between genotypes were
assessed using the PERMANOVA test for each sample type and
IgA status. Pairwise weighted and unweighted distances be-
tween IgA+ and IgA− samples for each mouse were tested with
linear mixed effects models for difference between the genotypes.
A linear mixed effects model was ﬁt on the log10 (IgA+/IgA−)
values to compare the magnitude of IgA response in MHCIIΔILC3
and H2-Ab1ﬂox/ﬂox control mice. Only the taxa with a mean
abundance of greater than 1% across samples were used for the
tests. Multiple tests were corrected for false discovery rate
using Benjamini-Hochberg method.
Real-time PCR
Total RNA was puriﬁed using the RNeasy Micro Kit (Qiagen),
and cDNA was prepared using the high-capacity cDNA reverse
transcription kit (Applied Biosystems). Real-time qPCR was
performed with the real-time PCR StepOnePlus system (Applied
Biosystems), using LightCycler 480 SYBR Green I Master Mix
(Roche) and with the following primers: Ebi2 forward, 59-ACA
ACGGAGGTCCTAGCCA-39; Ebi2 reverse, 59-GCTGTGGTGGGC
ATAGAGA-39; Cxcr5 forward, 59-GACCTTCAACCGTGCCTTTCT
C-39; Cxcr5 reverse, 59-GAACTTGCCCTCAGTCTGTAATCC-39;
Bcl6 forward, 59-CCTGTGAAATCTGTGGCACTCG-39; Bcl6 re-
verse, 59-CGCAGTTGGCTTTTGTGACG-39; Dll1 forward, 59-CTA
TGGCAAGGTCTGTGAGCTG-39; Dll1 reverse, 59-ATCTGAACA
TCGTCCTCCATTG-39; Tnfsf13 forward, 59-ACCCAGAAGCACAAG
AAGAAGC-39; Tnfsf13 reverse, 59-GTACTGGTTGCCACATCACCT
C-39; Il4 forward, 59-GAGAGATCATCGGCATTTTGA-39; Il4 re-
verse, 59-TCTGTGGTGTTCTTCGTTGC-39; Cd40l 59-GTGAGGAGA
TGAGAAGGCAA-39; Cd40l reverse, 59-CACTGTAGAACGGAT
GCTGC-39; Ifng forward, 59-GGAGGAACTGGCAAAAGGAT-39;
Ifng reverse, 59-TTCAAGACTTCAAAGAGTCTGAGG-39; Il17a
forward, 59-TGTGAAGGTCAACCTCAAAGTC-39; Il17a reverse,
59-AGGGATATCTATCAGGGTCTTCATT-39; Tgfb1 forward, 59-
CTGGGCACCATCCATGAC-39; Tgfb1 reverse, 59-CAGTTCTTCTCT
GTGGAGCTGA-39; bactin forward, 59-TCCTATGTGGGTGAC
GAG-39 and bactin reverse, 59-CTCATTGTAGAAGGTGTGGTG-39.
Real-time PCR was performed according to the Standard Ther-
mal Cycler Protocol. Samples were incubated for 95°C for
10 min, followed by denaturation for 15 s at 95°C and combined
annealing/extension for 1 min at 60°C for a total of 40 cycles.
Data were normalized to the housekeeping gene (bactin), ana-
lyzed using the 2–ΔΔCT method, and expressed relative to
control groups as indicated. TaqMan Gene Expression Assays
were additionally used for assessment of Il21 (Mm00517640_m1)
and hprt (Mm03024075_m1) expression (Applied Biosystems).
Bacterial 16S qPCR
Bacterial DNA samples were ampliﬁed using the following pri-
mers: total 16S forward, 59-ACTCCTACGGGAGGCAGCAGT-39; to-
tal 16S reverse, 59-ATTACCGCGGCTGCTGGC-39; total Helicobacter
forward, 59-GCTATGACGGGTATCC-39; total Helicobacter reverse,
59-GATTTTACCCCTACACCA-39; H. typhlonius forward, 59-AGG
GACTCTTAAATATGCTCCTAGAGT-39; H. typhlonius reverse, 59-
ATTCATCGTGTTTGAATGCGTCAA-39; H. hepaticus forward, 59-
GCATTTGAAACTGTTACTCTG-39; H. hepaticus reverse, 59-CTG
TTTTCAAGCTCCCCGAAG-39. Real-time qPCR was performed
with the real-time PCR StepOnePlus system (Applied Biosystems)
using the reagents and qPCR conditions stated above. Data were
normalized to the total bacteria (16S), analyzed using the 2–ΔΔCT
method, and expressed relative to control groups as indicated.
Intestinal metabolite analysis
The metabolic proﬁles of fecal samples were measured using 1H
NMR spectroscopy as previously described (Beckonert et al., 2007).
Brieﬂy, fecal samples (30 mg) were defrosted and combined with
600 µl of water and zirconium beads (0.45 g). Samples were ho-
mogenized with a Precellys 24 instrument (45 s per cycle, speed
6,500, two cycles) and spun at 14,000 × g for 10 min. The super-
natants (400 µl) were combined with 250 µl phosphate buffer (pH
7.4, 100% D2O, 3 mM NaN3, and 1 mM of 3-(trimethyl-silyl)-
[2,2,3,3-2H4]-propionic acid [TSP] for the chemical shift reference
at δ 0.0) before centrifugation at 14,000 × g for 10 min, and then
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transferred to 5 mmNMR tubes for analysis on a Bruker 600MHz
spectrometer operating at 300 K. 1H NMR spectra were acquired
for each sample using a standard one-dimensional pulse sequence
using the ﬁrst increment of the nuclear overhauser effect pulse
sequence forwater suppression as previously described (Beckonert
et al., 2007). Raw spectra were automatically phased, baseline-
corrected, and calibrated to TSP using Topspin 3.2 (Bruker Bio-
spin) and then digitized in a MATLAB environment (Version 2018;
MathWorks Inc.) using in-house scripts. Redundant spectral re-
gions (related to water and TSP resonance) were removed, and
the spectral data were manually aligned and normalized to the
probabilistic quotient using in-house MATLAB scripts. The peak
integrals (relating to relative abundance) for discriminatory
metabolites were calculated for each sample.
ELISA
Mouse fecal IgA titers were measured using the Mouse IgA
ELISA Quantitation Set (Bethyl Laboratories) following the
manufacturer’s instructions. Mouse fecal albumin was mea-
sured using the Mouse Albumin ELISA Quantitation Set (Bethyl
Laboratories) following the manufacturer’s instructions. For
both ELISAs, fecal samples were diluted 1/100 or 1/1,000, and
concentration was determined based on a standard curve. For
measurement of C. rodentium–speciﬁc antibodies in serum or
fecal supernatants by ELISA, 10 µg/ml C. rodentium antigen was
coated on 96-well plates, and sera were incubated in doubling
dilutions. Antigen-speciﬁc IgG and antigen-speciﬁc IgA were
detected using an anti-mouse IgG-HRP antibody (BD Bio-
sciences) and an anti-mouse IgA-HRP (Bethyl Laboratories). For
measurement of mouse IL-4 in cell culture, a capture anti-mouse
IL-4 antibody (clone 11B11; donated by A. MacDonald, University
of Manchester, Manchester, UK), recombinant mouse IL-4 (Bio-
Legend) and a detection biotinylated anti-mouse IL-4 antibody
(clone 24G2; BioLegend) were used. The mouse IL17A ELISA kit
(Invitrogen) were used to detect cytokines in cells stimulated
with C. rodentium antigen. Plates were developed with TMB
peroxidase substrate (BD Biosciences), and optical densities
were measured using a plate spectrophotometer.
C. rodentium infection
C. rodentium–eGFP has previously been described (Bergstrom
et al., 2010). Mice were infected with 109 CFUs of bacteria per
oral gavage, and bacterial burdens were measured in the feces by
plating serial dilutions onMacConkey agar plates and incubating
overnight at 37°C to quantify CFU per gram of fecal material.
In vitro coculture assay
Cocultures of ILC3, TfH, and B cells were performed using a pre-
viously described method (Sage and Sharpe, 2015), with minor
alterations. Brieﬂy, mice were subcutaneously immunized in the
ﬂank with 50 µg NP-OVA in CFA. 1 wk following immunization,
inguinal lymph nodes were harvested and enriched for B and T cell
populations by magnetic bead separation (Miltenyi Biotec) fol-
lowing themanufacturer’s instructions. Enriched populationswere
further sort-puriﬁed to >98% purity as live CD45+CD19+B220+
(B cells), or as live CD45+CD3+CD4+ICOS+CXCR5+GITR− TfH.
LTi-like ILC3 were sort-puriﬁed from naive mesenteric and
inguinal lymph nodes following preenrichment to deplete B cells,
as above, as CD45+Lineage−CD127+CD90+/intKLRG1−CCR6+. Com-
binations of B cells, TfH, and ILC3 were cultured in a ratio of
50,000:30,000:15,000 in the presence or absence of 2 µg/ml
anti-CD3, 5 µg/ml anti-IgM, and 20 µg/ml NP-OVA. Following
6 d of culture, cells were harvested and stained for CD19, B220,
GL7, CD38, and IgG1 to quantify B cell class switching.
Immunoﬂuorescence imaging
Colon tissue was ﬁxed in 1–2% paraformaldehyde (Sigma-Aldrich)
for 3 h at 4°C, washed three times in PBS for 10min, dehydrated in
a 10%→20%→30% sucrose gradient, and frozen in optimal cutting
temperature medium. 7-µm sections were cut and collected onto
Superfrost Plus slides (VWR). For staining, samples were hydrated
in 0.5% BSA/PBS for 10 min and incubated directly with B220
(RA3-6B2)-APC and GL7-FITC (1/200 dilution). Slides were
washed for 3 min in 0.5% BSA/PBS, stained for 10 min with DAPI,
and mounted with ProLong Gold (Invitrogen). Slides were visu-
alized under a ﬂuorescence microscope (Zeiss) or a slide scanner
microscope (Olympus), and images were processed with ImageJ.
Sections of mLN were prepared and stained for RORγt and CD3
expression as previously described (Mackley et al., 2015). Brieﬂy,
7-µm-thick sections of tissue were cut, ﬁxed in cold acetone at 4°C
for 20 min, and then stored at −20°C before staining. Antibodies
raised against the following mouse antigens were used: CD3 (1:50;
clone eBio500A2; eBioscience), IL-7Rα (1:25; clone A7R34; eBio-
science), and RORγt (1:30; clone AFKJS-9; eBioscience). Detection
of RORγt was achieved through ampliﬁcation of the primary
signal as described previously (Kim et al., 2011). Brieﬂy, puriﬁed
rat primary antibodies against RORγt were detected with donkey
anti-rat-IgG-FITC (1:150; Jackson ImmunoResearch), and subse-
quently rabbit anti-FITC-AF488 (1:200; Life Technologies) and
donkey anti-rabbit-IgG-AF488 (1:200; Life Technologies). Bi-
otinylated anti-CD3 antibodies were detected with SA-AF555
(1:500; Life Technologies). Expression of MHCII was detected
using anti-mouse I-A/I-E antibody conjugated to Alexa Fluor
647 (clone M5/114.15.2; BioLegend), as previously demonstrated
(Hepworth et al., 2015). Sections were counterstained with DAPI
(Invitrogen) andmounted using ProLong Gold (Invitrogen). Image
acquisition and analysis were performed with a Zeiss 780 Zen
microscope using Zen software.
FISH staining
For FISH, the colon was ﬁxed in Carnoy’s ﬁxative (60% methanol,
30% chloroform, and 10% acetic acid) overnight, washed in meth-
anol for 30min, and then stored in absolute ethanol until embedded
in parafﬁn. Longitudinal sections (5 µm) were hybridized to a
bacterial 16S rRNA gene probe: [Cy3] GCTGCCTCCCGTAGGAGT
(Euroﬁns Genomics). Sections were counterstained with DAPI
(Invitrogen) and mounted using ProLong Gold (Invitrogen). Slides
were visualized under a ﬂuorescence microscope (Zeiss) and im-
ages processed with ImageJ.
Statistical analyses
Results represent mean ± SEM. Statistical analyses were per-
formed by Student’s t test, Mann–Whitney U test, or one-way
ANOVA unless speciﬁed otherwise.
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Online supplemental material
Fig. S1 shows orchestration of ILC3 localization in the mLN. Fig.
S2 shows that antigen-presenting ILC3 limit TfH and B cell re-
sponses. Fig. S3 shows dysregulated IgA coating of commensal
bacteria and responses to enteric pathogens in the absence of
ILC3 antigen presentation.
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